In recent years, Wuhan Institute of Biological Products Co Ltd under CNBG, a bioscience subsidiary of Sinopharm, has pursued corporate growth by integrating the characteristics of the biomedicine sector and emphasizing technological innovation, product quality improvement and employee development. 

With a focus on enhancing brand identity and achieving commendable business performance, the company deems elevating employee satisfaction a key goal. 

One of the company's noteworthy achievements is its dedication to technological innovation, particularly in the context of the COVID-19 pandemic. Leveraging its advanced technology and talents, the company has undertaken comprehensive research in disease diagnosis, treatment and prevention. 

Within an impressive timeframe of 98 days, it secured the world’s first clinical approval for inactivated COVID-19 vaccines. In just 128 days, it simultaneously completed the construction of the world's first high-level biosafety production workshop and laboratory complex. 

To emphasize its commitment to industry-specific strengths, the company has organized skills competitions and knowledge contests to identify and nurture skilled professionals. Initiatives such as mentorship programs and collaborative projects have been introduced to further enhance its distinctive characteristics. 

Demonstrating a genuine concern for the well-being of its workforce, the company regularly organizes sports events such as tug-of-war, badminton and table tennis competitions, sports meetings and seasonal hiking trips. These activities not only promote a healthy lifestyle but also help foster a sense of camaraderie among employees. 

Innovative approaches to branding and public relations have been adopted, with the company creating platforms such as internal newsletters and a WeChat account to record achievements and showcase corporate image through text, images and videos. 

As part of its corporate social responsibility, the company has actively engaged in targeted poverty alleviation efforts through consumer-driven poverty reduction and donation initiatives. 

Additionally, the company has placed a strong emphasis on offering volunteer services. It has developed signature programs such as campaigns to take care of left-behind children. 

The recognition of Wuhan Institute of Biological Products Co Ltd as a model unit in Hubei province reflects its multifaceted commitment to innovation of excellence and social responsibility within the biopharmaceutical industry.